NeoGenomics, Inc.NEONASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+6.9%
5Y CAGR+35.1%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+6.9%/yr
vs +78.3%/yr prior
5Y CAGR
+35.1%/yr
Recent deceleration
Acceleration
-71.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.5x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$37.08M+19.0%
2024$31.16M+14.1%
2023$27.31M-9.9%
2022$30.33M+38.6%
2021$21.87M+165.8%
2020$8.23M-3.0%
2019$8.49M+182.8%
2018$3.00M-17.5%
2017$3.64M-21.8%
2016$4.65M-